Accolade Inc (ACCD)
7.46
-0.18
(-2.36%)
USD |
NASDAQ |
May 01, 11:33
Accolade Enterprise Value: 570.53M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 30, 2024 | 570.53M |
April 29, 2024 | 613.63M |
April 26, 2024 | 590.12M |
April 25, 2024 | 691.99M |
April 24, 2024 | 708.44M |
April 23, 2024 | 704.52M |
April 22, 2024 | 693.55M |
April 19, 2024 | 687.29M |
April 18, 2024 | 687.80M |
April 17, 2024 | 651.10M |
April 16, 2024 | 627.68M |
April 15, 2024 | 641.73M |
April 12, 2024 | 615.97M |
April 11, 2024 | 649.54M |
April 10, 2024 | 670.62M |
April 09, 2024 | 721.37M |
April 08, 2024 | 697.16M |
April 05, 2024 | 689.36M |
April 04, 2024 | 694.04M |
April 03, 2024 | 702.63M |
April 02, 2024 | 721.37M |
April 01, 2024 | 762.74M |
March 28, 2024 | 790.07M |
March 27, 2024 | 751.81M |
March 26, 2024 | 749.47M |
Date | Value |
---|---|
March 25, 2024 | 728.39M |
March 22, 2024 | 712.78M |
March 21, 2024 | 733.08M |
March 20, 2024 | 739.32M |
March 19, 2024 | 723.71M |
March 18, 2024 | 715.90M |
March 15, 2024 | 692.48M |
March 14, 2024 | 718.24M |
March 13, 2024 | 713.56M |
March 12, 2024 | 706.53M |
March 11, 2024 | 718.24M |
March 08, 2024 | 713.56M |
March 07, 2024 | 715.90M |
March 06, 2024 | 706.53M |
March 05, 2024 | 691.70M |
March 04, 2024 | 719.81M |
March 01, 2024 | 749.47M |
February 29, 2024 | 772.11M |
February 28, 2024 | 790.17M |
February 27, 2024 | 804.87M |
February 26, 2024 | 810.29M |
February 23, 2024 | 769.27M |
February 22, 2024 | 800.23M |
February 21, 2024 | 868.35M |
February 20, 2024 | 882.67M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
270.72M
Minimum
May 11 2022
3.486B
Maximum
Jun 29 2021
1.383B
Average
1.008B
Median
Apr 14 2023
Enterprise Value Benchmarks
HealthStream Inc | 699.99M |
HealthEquity Inc | 7.270B |
Trxade Health Inc | 15.15M |
Simulations Plus Inc | 797.81M |
Schrodinger Inc | 1.301B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -7.507M |
Revenue (Quarterly) | 124.83M |
Total Expenses (Quarterly) | 132.73M |
EPS Diluted (Quarterly) | -0.10 |
Gross Profit Margin (Quarterly) | 53.38% |
Profit Margin (Quarterly) | -6.01% |
Earnings Yield | -17.89% |
Normalized Earnings Yield | -17.89 |